Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4 publications
The spectrum of response to erenumab in patients with chronic migraine and subgroup analysis of patients achieving ≥50%, ≥75%, and 100% response.
Journal: Cephalalgia : an international journal of headache
Published: December 10, 2019
Long-term study of the efficacy and safety of OnabotulinumtoxinA for the prevention of chronic migraine: COMPEL study.
Journal: The journal of headache and pain
Published: October 13, 2017
Showing 1-4 of 4
Last Updated: 09/26/2026